EMA/WHO hatch plan to speed approvals in developing countries
This article was originally published in Scrip
Executive Summary
The World Health Organization and the European Medicines Agency are to take part in a pilot project intended to make it easier for medicines authorized for marketing in Europe to be licensed in developing countries where regulators may not have all the resources needed to operate their key regulatory functions.